One of the most vexing aspects of the COVID-19 pandemic is doctors’ inability to predict which newly hospitalized […]
Category: Uncategorized
Investments in health research are not fully realised because of delayed and variable uptake of effective interventions by […]
Approval is based on results from the Phase III DESTINY-Gastric01 trial
Lead asset REX-001 is in Phase III development for chronic limb-threatening ischaemia
Therapy approved for the treatment of paediatric patients with anaplastic large cell lymphoma
Partnership aims to transform HIV patient care with digital services
Updated Date: Fri, 08 Jan 2021 00:00:00 EST
Updated Date: Fri, 08 Jan 2021 00:00:00 EST
Updated Date: Fri, 08 Jan 2021 00:00:00 EST
